13406-98-9Relevant articles and documents
Kinetics and mechanisms of gas phase elimination of ethyl 1-piperidine carboxylate, ethyl pipecolinate, and (revisited) ethyl 1-methyl pipecolinate
Rosas, Felix,Monsalve, Angiebelk,Tosta, Maria,Herize, Armando,Dominguez, Rosa M.,Brusco, Doris,Chuchani, Gabriel
, p. 383 - 389 (2005)
The kinetics of the gas-phase elimination of the title compounds has been determined in a static reaction system over the temperature range of 340-420°C and pressure range of 45-96 Torr. The reactions proved to be homogeneous, unimolecular, and obey a first-order rate law. The estimated rate coefficients are represented by the following Arrhenius expressions: Ethyl 1-piperidine carboxylate log k1 (S-1) = (12.61 ± 0.11) - (191.1 ± 1.4) kJ mol-1 (2.303 RT)-1, r = 0.9999 Ethyl pipecolinate log k1 (S-1) = (12.87 ± 0.16) - (204.3 ± 2.1) kJ mol-1 (2.303 RT)-1, r = 0.9998 Ethyl 1-methyl pipecolinate log k1 (S-1) = (13.34 ± 0.32) - (209.4 ± 4.0) kJmol-1 (2.303 RT) -1, r = 0.9992 The first step of decomposition of these esters is the formation of the corresponding carboxylic acids and ethylene. The acid intermediate undergoes a very fast decarboxylation process. The mechanism of this elimination reactions is suggested on the basis of the kinetic and thermodynamic parameters.
Highly efficient and selective formation of hydrogencarbonate in CO 2 absorption process using piperidine and piperazine derivatives
Shin, Man Sub,Park, Yoon Kook,Nam, Sung Chan,Hwang, Kwang-Jin
experimental part, p. 142 - 144 (2012/03/10)
This investigation demonstrated that bicarbonate ions were selectively formed over carbamate in a CO2 absorption process using piperidine and piperazine derivatives based on 13CNMR. Piperidines with methyl or hydroxymethyl substituent at 2 position (PiP-Me and PiP-MeOH) and 2,5-dimethylpiperazine (DM-PiZ) generated the bicarbonate ions as main adducts in reaction with CO2. The absorptions of CO2 by those aqueous amines (PiP-Me and DM-PiZ) were faster than those of MEA (2-aminoethanol).
Cyclic hydroxamic acids as metalloproteinase inhibitors
-
, (2008/06/13)
The present application de gibes novel cyclic hydroxamic acids of formula I: or pharmaceutically acceptable salt forms thereof, wherein ring B is a 5-7 membered cyclic system containing from 0-2 heteroatoms selected from O, N, NRa, and S(O)p, and 0-1 carbonyl groups and the other variables are defined in the present specification, which are useful as metalloprotease inhibitors.